Skip to content

Yoga for Sarcopenia: A Randomized Controlled Trial

Effect of Yoga Intervention on Functional Performance in Elderly with Sarcopenia: A Prospective Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/092078
Enrollment
92
Registered
2025-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M628- Other specified disorders of muscle

Interventions

Intervention1: YI: Yogic intervention: The proposed yogic intervention involves a 45-minute session of low to moderate intensity yoga practices including physical postures(padmasadhana series), breath

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age Group/Gender- 60 to 70 yr, Male & Female 2. Having SARC-F score greater or equal to 4 (possible sarcopenia) and sarcopenia, as per the AWGS 2019 community guidelines 3. Subjects practicing less than 150 min. of exercise per week 4. Willing to comply with the study procedures and provide a written informed consent

Exclusion criteria

Exclusion criteria: 1. Known cases of chronic kidney disease, chronic liver disease, primary malignancy, osteoarthritis, uncontrolled diabetes ,uncontrolled hypertension, HIV, on ICD and stroke. 2. Diagnosed cases of psychiatric disorders like severe depression, schizophrenia. 3. Active infections or sepsis. 4. Recent trauma, fractures, major surgeries (CABG, lower limb hip or knee replacement, renal transplants ), musculoskeletal pains or any dysfunction that prevents physical activity. 5. Subjects on anabolic steroids, glucocorticoids, chemotherapy, antituberculosis drugs and thyroxine.

Design outcomes

Primary

MeasureTime frame
Physical Performance Evaluated by Short Physical Performance Battery (SPPB)Timepoint: Day 0 (baseline), Day 45 (midpoint), and Day 90 (post-intervention)

Secondary

MeasureTime frame
Muscle Mass: Appendicular skeletal muscle mass (ASM) measured via bioelectrical impedance analysis (BIA)Timepoint: Day 0 (baseline), Day 45 (midpoint), and Day 90 (post-intervention);Muscle Strength: Maximum grip strength measured using a calibrated hand dynamometer.Timepoint: Day 0 (baseline), Day 45 (midpoint), and Day 90 (post-intervention);Muscle Stem cell activation: Concentration of PAX7 & MYF5 protein (ng/mL) in serum, measured via ELISATimepoint: Day 0 (baseline) and Day 90 (post-intervention);Cognitive Assessment: MoCA questionnaire: Montreal Cognitive assessment questionnaire based assessment of cognitionTimepoint: Day 0 (baseline), Day 45 (midpoint), and Day 90 (post-intervention;Quality of Life: Questionnaire based assessment of quality of life, using Sarcopenia related quality of life (SarQoL) questionnaireTimepoint: Day 0 (baseline), Day 45 (midpoint), and Day 90 (post-intervention)

Countries

India

Contacts

Public ContactDr Monika Pathania

AIIMS Rishikesh

Sumitbhardwaaj1@gmail.com9084389392

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026